国际肿瘤学杂志 ›› 2023, Vol. 50 ›› Issue (4): 244-247.doi: 10.3760/cma.j.cn371439-20230208-00048
收稿日期:
2023-02-08
修回日期:
2023-03-12
出版日期:
2023-04-08
发布日期:
2023-06-12
通讯作者:
汪红艳,Email: 基金资助:
Received:
2023-02-08
Revised:
2023-03-12
Online:
2023-04-08
Published:
2023-06-12
Contact:
Wang Hongyan, Email: Supported by:
摘要:
放疗是腹部及盆腔肿瘤的重要治疗方法,但其不良反应放射性肠炎的发生率较高。腹部及盆腔放疗可诱导肠道隐窝细胞凋亡、破坏肠道屏障、改变肠道菌群组成,肠道菌群失调可加重放射性肠炎。粪便菌群移植及使用益生菌、益生元、抗生素等可调节肠道菌群,是预防和治疗放射性肠炎的有效方法。
石小琪, 汪红艳. 肠道菌群与放射性肠炎的相互作用及研究进展[J]. 国际肿瘤学杂志, 2023, 50(4): 244-247.
Shi Xaioqi, Wang Hongyan. Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247.
[1] |
Araujo IK, Muñoz-Guglielmetti D, Mollà M. Radiation-induced damage in the lower gastrointestinal tract: clinical presentation, diagnostic tests and treatment options[J]. Best Pract Res Clin Gastroenterol, 2020, 48/49: 101707. DOI: 10.1016/j.bpg.2020.101707.
doi: 10.1016/j.bpg.2020.101707 |
[2] |
Zhao TS, Xie LW, Cai S, et al. Dysbiosis of gut microbiota is associated with the progression of radiation-induced intestinal injury and is alleviated by oral compound probiotics in mouse model[J]. Front Cell Infect Microbiol, 2021, 11: 717636. DOI: 10.3389/fcimb.2021.717636.
doi: 10.3389/fcimb.2021.717636 |
[3] |
Wang L, Wang X, Zhang G, et al. The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review[J]. Radiat Oncol, 2021, 16(1): 187. DOI: 10.1186/s13014-021-01899-y.
doi: 10.1186/s13014-021-01899-y pmid: 34563216 |
[4] |
Badgeley A, Anwar H, Modi K, et al. Effect of probiotics and gut microbiota on anti-cancer drugs: mechanistic perspectives[J]. Biochim Biophys Acta Rev Cancer, 2021, 1875(1): 188494. DOI: 10.1016/j.bbcan.2020.188494.
doi: 10.1016/j.bbcan.2020.188494 |
[5] |
Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy[J]. Nat Rev Cancer, 2017, 17(5): 271-285. DOI: 10.1038/nrc.2017.13.
doi: 10.1038/nrc.2017.13 pmid: 28303904 |
[6] |
Sokol H, Adolph TE. The microbiota: an underestimated actor in radiation-induced lesions?[J]. Gut, 2018, 67(1): 1-2. DOI: 10.1136/gutjnl-2017-314279.
doi: 10.1136/gutjnl-2017-314279 pmid: 28473631 |
[7] |
Liu J, Liu C, Yue J. Radiotherapy and the gut microbiome: facts and fiction[J]. Radiat Oncol, 2021, 16(1): 9. DOI: 10.1186/s13014-020-01735-9.
doi: 10.1186/s13014-020-01735-9 pmid: 33436010 |
[8] |
Suzuki T. Regulation of intestinal epithelial permeability by tight junctions[J]. Cell Mol Life Sci, 2013, 70(4): 631-659. DOI: 10.1007/s00018-012-1070-x.
doi: 10.1007/s00018-012-1070-x pmid: 22782113 |
[9] |
De Ruysscher D, Niedermann G, Burnet NG, et al. Radiotherapy toxicity[J]. Nat Rev Dis Primers, 2019, 5(1): 13. DOI: 10.1038/s41572-019-0064-5.
doi: 10.1038/s41572-019-0064-5 pmid: 30792503 |
[10] |
Lu L, Li W, Chen L, et al. Radiation-induced intestinal damage: latest molecular and clinical developments[J]. Future Oncol, 2019, 15(35): 4105-4118. DOI: 10.2217/fon-2019-0416.
doi: 10.2217/fon-2019-0416 pmid: 31746639 |
[11] |
Li Y, Yan H, Zhang Y, et al. Alterations of the gut microbiome composition and lipid metabolic profile in radiation enteritis[J]. Front Cell Infect Microbiol, 2020, 10: 541178. DOI: 10.3389/fcimb.2020.541178.
doi: 10.3389/fcimb.2020.541178 |
[12] |
Jian Y, Zhang D, Liu M, et al. The impact of gut microbiota on radiation-induced enteritis[J]. Front Cell Infect Microbiol, 2021, 11: 586392. DOI: 10.3389/fcimb.2021.586392.
doi: 10.3389/fcimb.2021.586392 |
[13] |
Goldenberg JZ, Yap C, Lytvyn L, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children[J]. Cochrane Database Syst Rev, 2017, 12(12): CD006095. DOI: 10.1002/14651858.CD006095.pub4.
doi: 10.1002/14651858.CD006095.pub4 |
[14] |
Liu MM, Li ST, Shu Y, et al. Probiotics for prevention of radiation-induced diarrhea: a meta-analysis of randomized controlled trials[J]. PLoS One, 2017, 12(6): e0178870. DOI: 10.1371/journal.pone.0178870.
doi: 10.1371/journal.pone.0178870 |
[15] |
Linn YH, Thu KK, Win NHH. Effect of probiotics for the prevention of acute radiation-induced diarrhoea among cervical cancer patients: a randomized double-blind placebo-controlled study[J]. Probiotics Antimicrob Proteins, 2019, 11(2): 638-647. DOI: 10.1007/s12602-018-9408-9.
doi: 10.1007/s12602-018-9408-9 pmid: 29550911 |
[16] |
Qiu G, Yu Y, Wang Y, et al. The significance of probiotics in preventing radiotherapy-induced diarrhea in patients with cervical cancer: a systematic review and meta-analysis[J]. Int J Surg, 2019, 65: 61-69. DOI: 10.1016/j.ijsu.2019.03.015.
doi: S1743-9191(19)30073-1 pmid: 30928672 |
[17] |
Riehl TE, Alvarado D, Ee X, et al. Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells[J]. Gut, 2019, 68(6): 1003-1013. DOI: 10.1136/gutjnl-2018-316226.
doi: 10.1136/gutjnl-2018-316226 pmid: 29934438 |
[18] |
Guo H, Chou WC, Lai Y, et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites[J]. Science, 2020, 370(6516): eaay9097. DOI: 10.1126/science.aay9097.
doi: 10.1126/science.aay9097 |
[19] |
Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(8): 491-502. DOI: 10.1038/nrgastro.2017.75.
doi: 10.1038/nrgastro.2017.75 pmid: 28611480 |
[20] |
Garcia-Peris P, Velasco C, Hernandez M, et al. Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: a randomized, double-blind, placebo-controlled trial[J]. Eur J Clin Nutr, 2016, 70(2): 170-174. DOI: 10.1038/ejcn.2015.192.
doi: 10.1038/ejcn.2015.192 pmid: 26603881 |
[21] |
García-Peris P, Velasco C, Lozano MA, et al. Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial[J]. Nutr Hosp, 2012, 27(6): 1908-1915. DOI: 10.3305/nh.2012.27.6.5992.
doi: 10.3305/nh.2012.27.6.5992 pmid: 23588438 |
[22] |
Zhao Z, Cheng W, Qu W, et al. Antibiotic alleviates radiation-induced intestinal injury by remodeling microbiota, reducing inflammation, and inhibiting fibrosis[J]. ACS Omega, 2020, 5(6): 2967-2977. DOI: 10.1021/acsomega.9b03906.
doi: 10.1021/acsomega.9b03906 pmid: 32095719 |
[23] |
Uribe-Herranz M, Rafail S, Beghi S, et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response[J]. J Clin Invest, 2020, 130(1): 466-479. DOI: 10.1172/JCI124332.
doi: 10.1172/JCI124332 pmid: 31815742 |
[24] |
Cui M, Xiao H, Li Y, et al. Faecal microbiota transplantation protects against radiation-induced toxicity[J]. EMBO Mol Med, 2017, 9(4): 448-461. DOI: 10.15252/emmm.201606932.
doi: 10.15252/emmm.201606932 pmid: 28242755 |
[25] |
Liu T, Su D, Lei C, et al. Treatment of radiation enteritis with fecal transplantation[J/OL]. Am Surg. (2022-06-12)[2023-01-12]. https://pubmed.ncbi.nlm.nih.gov/35695221/. DOI: 10.1177/00031348221091954.
doi: 10.1177/00031348221091954 |
[26] |
Bak SH, Choi HH, Lee J, et al. Fecal microbiota transplantation for refractory Crohn's disease[J]. Intest Res, 2017, 15(2): 244-248. DOI: 10.5217/ir.2017.15.2.244.
doi: 10.5217/ir.2017.15.2.244 pmid: 28522956 |
[27] |
Johnsen PH, Hilpüsch F, Cavanagh JP, et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial[J]. Lancet Gastroenterol Hepatol, 2018, 3(1): 17-24. DOI: 10.1016/S2468-1253(17)30338-2.
doi: 10.1016/S2468-1253(17)30338-2 |
[28] |
韦丽娅, 郭智. 肠道微生物群与血液肿瘤[J]. 国际肿瘤学杂志, 2021, 48(7): 445-448. DOI: 10.3760/cma.j.cn371439-20201019-00086.
doi: 10.3760/cma.j.cn371439-20201019-00086 |
[29] |
Ding X, Li Q, Li P, et al. Fecal microbiota transplantation: a promising treatment for radiation enteritis?[J]. Radiother Oncol, 2020, 143: 12-18. DOI: 10.1016/j.radonc.2020.01.011.
doi: S0167-8140(20)30023-2 pmid: 32044171 |
[30] |
Xiao HW, Cui M, Li Y, et al. Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein[J]. Microbiome, 2020, 8(1): 69. DOI: 10.1186/s40168-020-00845-6.
doi: 10.1186/s40168-020-00845-6 |
[31] |
Wang C, Xie J, Dong X, et al. Clinically approved carbon nano-particles with oral administration for intestinal radioprotection via protecting the small intestinal crypt stem cells and maintaining the balance of intestinal flora[J]. Small, 2020, 16(16): e1906915. DOI: 10.1002/smll.201906915.
doi: 10.1002/smll.201906915 |
[32] |
Li Y, Dong J, Xiao H, et al. Caloric restriction alleviates radiation injuries in a sex-dependent fashion[J]. FASEB J, 2021, 35(8): e21787. DOI: 10.1096/fj.202100351RR.
doi: 10.1096/fj.202100351RR |
[1] | 张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375. |
[2] | 高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381. |
[3] | 李书月, 马辰莺, 周菊英, 徐晓婷, 秦颂兵. 寡转移非小细胞肺癌的放疗进展[J]. 国际肿瘤学杂志, 2024, 51(3): 170-174. |
[4] | 李济时, 陆钊群, 刘俊茹, 吕建勋, 陈霜, 沈琳, 徐志渊, 吴平安. 新辅助放疗联合部分喉切除术治疗喉滑膜肉瘤1例并文献复习[J]. 国际肿瘤学杂志, 2024, 51(2): 123-125. |
[5] | 中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会. 中国食管癌放射治疗指南(2023年版)[J]. 国际肿瘤学杂志, 2024, 51(1): 1-20. |
[6] | 高新雨, 李振江, 孙洪福, 韩丹, 赵倩, 刘成新, 黄伟. 基于MR加速器的MR引导放疗在食管癌患者中的临床应用[J]. 国际肿瘤学杂志, 2024, 51(1): 37-42. |
[7] | 崔腾璐, 吕璐, 孙鹏飞. 放疗联合免疫治疗在头颈部鳞状细胞癌治疗中的应用[J]. 国际肿瘤学杂志, 2023, 50(9): 548-552. |
[8] | 过慈良, 江春平, 吴俊华. 肠道菌群与肿瘤免疫治疗[J]. 国际肿瘤学杂志, 2023, 50(7): 432-436. |
[9] | 李青珊, 谢鑫, 张楠, 刘帅. 放疗联合系统治疗在乳腺癌中的应用进展[J]. 国际肿瘤学杂志, 2023, 50(6): 362-367. |
[10] | 吕璐, 孙鹏飞. 肠道菌群与宫颈癌[J]. 国际肿瘤学杂志, 2023, 50(6): 373-376. |
[11] | 许萌, 姜伟, 朱海涛, 曹雄锋. 癌相关成纤维细胞在肿瘤放疗抵抗中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(4): 227-230. |
[12] | 李进芝, 赵彪, 文晓博, 张明, 袁美芳, 孙梦真, 蒲琴, 杨毅. Monaco系统计算网格尺寸对T4期鼻咽癌的剂量学影响[J]. 国际肿瘤学杂志, 2023, 50(11): 641-649. |
[13] | 耿睿, 马俊强, 郭强, 牛钊峰. 老年乳腺癌患者的综合治疗方式选择倾向及其影响因素[J]. 国际肿瘤学杂志, 2023, 50(11): 650-654. |
[14] | 王冰, 王爱馥, 刘雯舒, 范娇娇, 田伟成, 王玮莉, 刘博宇. 重组人血小板生成素治疗肿瘤放疗所致血小板减少症的疗效及安全性[J]. 国际肿瘤学杂志, 2023, 50(11): 661-667. |
[15] | 中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会. 新型冠状病毒感染疫情背景下肿瘤患者放射治疗管理相关问题中国专家共识(2023版)[J]. 国际肿瘤学杂志, 2023, 50(10): 577-584. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||